Table 1.
Baseline clinical characteristics of the FINRISK 2002 study cohort in persons without prevalent major adverse cardiovascular event, stratified by CERT2 risk categories
| Characteristic | CERT2: 0–3 | CERT2: 4–6 | CERT2: 7–8 | CERT2: 9–12 |
|---|---|---|---|---|
| N | 1210 | 3089 | 1870 | 1155 |
| Sex (male) (%) | 42 | 44 | 48 | 52 |
| Age (years) | 41 (32–52) | 46 (36–56) | 49 (39–58) | 55 (44–62) |
| Diabetes (%) | 4 | 4 | 6 | 7 |
| Current smoker (%) | 17 | 23 | 29 | 37 |
| Lipid treatment (%) | 6 | 6 | 4 | 4 |
| Antihypertensive treatment (%) | 8 | 13 | 14 | 17 |
| BMI (kg/m2) | 24.9 (22.5–27.5) | 26.1 (23.4–28.9) | 26.7 (24.1–30.1) | 27.4 (24.4–30.4) |
| Systolic blood pressure (mmHg) | 126 (117–138) | 131 (120–145) | 133 (121–148) | 138 (125–153) |
| TC (mmol/L) | 5.0 (4.5–5.6) | 5.4 (4.8–6.1) | 5.6 (5.0–6.4) | 6.0 (5.3–6.7) |
| LDL-C (mmol/L) | 2.9 (2.5–3.4) | 3.2 (2.7–3.8) | 3.5 (2.9–4.1) | 3.7 (3.1–4.4) |
| HDL-C (mmol/L) | 1.5 (1.3–1.8) | 1.5 (1.2–1.8) | 1.4 (1.2–1.7) | 1.4 (1.1–1.7) |
| TG (mmol/L) | 1.0 (0.8–1.4) | 1.1 (0.8–1.6) | 1.2 (0.9–1.8) | 1.3 (1.0–2.0) |
For continuous variables, median and IQR are presented.
BMI, body mass index; HDL-C, HDL-cholesterol; IQR, interquartile range; LDL-C, LDL-cholesterol; TC, total cholesterol; TG, triglycerides.